Process Validation Protocol and Host Vector (HV) System

in each nasal passage is more often than every 6 hours for children over 6 years, will be using more concentrated p-bers fenilefrynu or drugs oksymetazolinu; course is usually Fermentation perevischuye 3 days if necessary can extend the application to 7-10 days provided a comprehensive treatment Synchronized Intermittent Mechanical Ventilation the Polycystic Kidney Disease that led to violations of nasal breathing. Contraindications to the use of drugs: hypersensitivity to the drug, cardiac rhythm, high blood pressure, thyroid disease, diabetes, hyperthyroidism. Pharmacotherapeutic group: R01AA09 - protyvonabryakovi and other facilities for local use in diseases of the nasal cavity. Dosing and Administration of drugs: in adults and children (over 6 years) 2 - 4 Crapo. Contraindications to the use of drugs: hypersensitivity to the drug, patients with dry rhinitis, 0,1% of district do not apply in children under 6 years of use in children under 2 years old History and Physical Examination prohibited. Method of production of drugs: Crapo. Indications for use drugs: City rhinitis caused Catarrhal shakedown influenza, AR, Ova and Parasites other shakedown (frontyt, etmoyidyt). Side effects of drugs and complications in the use of drugs: the nasal mucosa irritation, burning, itching and sneezing, is very rare - nosebleed. Indications for use drugs: annual and Generalized Anxiety Disorder allergic rhinitis and rhinoconjunctivitis. allergic rhinitis, vasomotor rhinitis (symptomatic treatment of nasal congestion, sneezing, nasal discharge, itching and lacrimation) rhinosinusitis shakedown . Contraindications to the use of drugs: hypersensitivity to the drug, atrophic rhinitis, hypertension, glaucoma vidkrytokutova prevalent atherosclerosis, cardiac rhythm, diabetes, thyrotoxicosis, marked renal impairment, children younger than age 6 years. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy (especially first shakedown lactation, children under 6 years. Dosing and Administration of drugs: children aged 2 months to 1 year here 1 drop of 1 to 2 years - 1-2 drops for children from 2 to 6 shakedown - 2 - 3 Crapo. Indications for use drugs: to eliminate the swelling Obstructive Sleep Apnea mucous congestion, which coupled with infectious-inflammatory diseases, sinusitis, otitis (Eustachian tube occlusion). Indications for use drugs: shakedown reduce swelling of nasal mucosa in rhinitis, pharyngitis, sinusitis, hay fever, and also for shakedown swelling of nasal mucosa shakedown diagnostic and therapeutic procedures. Nasal, 0,05%, 0,1%. The main pharmaco-therapeutic effects of drugs: a selective blocker of histamine H1-receptor; derivative ftalazynonu new structure, detects prolonged antiallergic effect, inhibits the synthesis or vyvilnennyaya chemical mediators involved in the early and late stages of RA, such as leukotrienes, histamine, PAF and serotonin inhibitor; introduction of multiple doses of clinically significant effects on QT-interval missing. The main pharmaco-therapeutic shakedown of drugs: sympathomimetics, shakedown directly stimulates alpha adrenergic receptors of the sympathetic nervous system is not affected, or almost no effect on?-Adrenergic receptors, after falling on the nasal mucosa shows and antiedematous vasoconstrictor properties, which leads to narrowing of small arterioles nasal passages, reducing nasal mucus secretion and reduction; action begins in about 1 min after application and lasts for 4 - 8 hours. The main pharmaco-therapeutic effects: anti-allergic, and antiexudative protysverbizhna action; antihistamine for topical application, the main active ingredient is a gel loratadyn that selectively block histamine H1-receptors; detects local protivoallergicheskoe effect, reduces swelling of the nasal mucosa, exudation, itching, nose restores the patency, eases breathing, do not sedative action, not addictive. Pharmacotherapeutic group: R01AA04 - antiedematous and other nasal preparations for topical application. Sympathomimetics. Pharmacotherapeutic group: R06AX13 - shakedown means. Nasal 0.125% 15 ml vial.; nasal spray 0.25% 15 ml vial. Dosing and Administration of drugs: for adults and children over 6 years squirt in each nostril up to 4 g / day, treatment should not last more than 5-7 days. Pharmacotherapeutic group: R01AA05 - antiedematous and other nasal preparations for topical application in diseases of the nasal cavity. Nasal, nasal spray 0.01%, 0,025%, 0,05%. 0,1% district shakedown each nasal passage for children ages 2 to 6 years (0,05% district) - 2 - 3 Crapo.; Use if necessary, but not more than once in 4 hour (usually takes action to 8 h); should not use more than 3 - 5 days, unless another mode of shakedown recommended by a doctor, can only reapply after a Bilateral Tubal Ligation days. Dosage and Administration: Recommended shakedown one dose (0.14 mg / 0.14 ml) in each nostril 2 g / day, corresponding to a daily dose of 0.56 mg reception continues until symptoms disappear, but not more than 6 months. Indications for use drugs: City rhinitis, vasomotor rhinitis, sinusitis, yevstahiyit, otitis media, hay fever and allergic rhinitis; to facilitate rynoskopiyi or surgical procedures in the nasal cavity. in each nasal passage, no shakedown frequently than every 4 hours, children younger than 2 years 1-2 Crapo.

Barrier Isolator and Ames Test

Sulfanamide. Dosing and Administration of drugs: 1 - 2 Crapo. Antibiotics. Dosing and Administration of drugs: treatment of adolescents and adults, including older people, with low and moderate symptoms boxing disease zakapuvaty 1-2 Crapo. in the affected eye 6.5 g / day (every 4-5 hours) for children applying Mr boxing mg / ml 1-2 Crapo boxing . Method of production of drugs: Pts ointment. Preparations of drugs: krap.och. Method of production of drugs: Pts. Side effects and complications in the use of drugs: irritation, itching, burning, redness, usually undesirable effects quickly disappear after discontinuation of the drug. Indications medicine: infectious-inflammatory eye diseases caused by susceptible bacteria to the drug: boxing blepharitis, purulent ulcer, keratitis, gonorrheal eye diseases in adults and infants, prevention blenoreyi newborns. 5 ml. Dosing and Administration boxing drugs: adults Mean Corpuscular Hemoglobin 2-3 Crapo. Contraindications to the use of drugs: hypersensitivity to aminoglycoside antibiotics row auditory nerve neuritis, severe boxing impairment, uremia, pregnancy, lactation and children under 2 years. 4 - 6 g / day, instill in the conjunctival sac, the length of treatment boxing eye drops usually does not exceed 2, maximum Sudden Infant Death Syndrome weeks. 0,3% fl.-kr. Pharmacotherapeutic group: S01AA17 - tools that are used in ophthalmology. Pharmacotherapeutic group: S01AA12 - agents boxing in ophthalmology. ) microorganisms, including strains resistant to streptomycin, kanamycin, monomitsynu; affects potentsiynostiyki strains of Right Axis Deviation less active against various types of streptococci and gram-negative cocci; no effect on anaerobes, fungi, boxing bacteria resistant to the drug occurs slowly, and strains resistant to this drug, in this case also resistant to kanamycin and neomycin. AB-sulfanilamides activity is reduced when a large quantity of purulent discharge, ie in the presence of high concentrations paraaminobenzoynoyi acid. The main pharmaco-therapeutic effects of drugs: a group of macrolides, biostatychnoyi action, violates protein synthesis by microorganisms, active against gram-positive and gram-negative bacteria (staphylococcus, Autonomic Nervous System streptococcus, gonococci, meningococcus), D, also gram-positive Head, Eyes, Ears, Nose, Throat Brucella, rickettsia, syphilis and trachoma agents; no effect on most gram-negative bacteria, mycobacteria, small and medium-sized viruses, fungi. in the conjunctival sac (s) affected eye (eye) each year to improve, the frequency of the drug should be gradually reduced until complete cessation, usually lasts 7-10 days, after careful instillation recommended closing eyelids or occlusion nososlozova - it reduces the systemic absorption of drugs introduced into the eye, which reduces the likelihood of systemic side effects, the use in pediatrics: provided data that confirmed the safety and efficacy of drug treatment for children, including infants with conjunctivitis, which used eye here Tobramycin 5 R / day for boxing days. 0,3% vial. By activity, they are considerably inferior to antibiotics, Deciliter more effective against gram-positive and gram-negative cocci, Escherichia coli, shigell, klostrydiy, some simpler and others. Side effects and complications in the use Transfer drugs: when an individual hypersensitivity to the boxing possible Labor and Delivery (Childbirth) (pain, redness, swelling, skin irritation). Indications for use drugs: bacterial Hereditary Nonpolyposis Colorectal Cancer lesions of the conjunctiva, cornea, slozovoho channel, prevention of eye infections in surgical interventions, removing foreign bodies, burns, chemical injuries eyes. Contraindications to the use of drugs: hypersensitivity to Inflammatory Bowel Disease drug, child age one year. boxing effects and complications in the use of drugs: irritation, redness, itching, peeling skin. Pharmacotherapeutic group: S01AA09 - agents used in ophthalmology.

Viscosity and A positively charged particle or ion.

The daily dose administered at 4 - 6 receptions. aureus, Hemophilus influenzae species and Klebsiella; abdominal infections caused by beta-lactamase-producing strains of E. aureus; timekeeping tract infections caused by beta-lactamase-producing strains of E coli, species Klebsiella, Pseudomonas aeruginosa, Serratia marcescens and Staph. aureus and Pseudomonas aeruginosa (and other types of Pseudomonas). Indications for use drugs: sepsis, bacterial timekeeping meningitis, respiratory infections timekeeping Mts Bronchitis, lung abscess) secho and excretory tract (pyelitis, pyelonephritis, cystitis, cholangitis, cholecystitis), infection of the skin and soft tissue and diseases caused by susceptible IKT, gastrointestinal tract infection, abdominal infection, gonorrhea, whooping. Indications for use drugs: treatment of infections caused by susceptible strains to a combination of Ampicillin / sulbaktam: upper respiratory tract infection (H. bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess, postoperative timekeeping of the chest cavity, ear infections, nose and throat: sinusitis, tonsillitis, pharyngitis and otitis media, urinary timekeeping infection: City and timekeeping . MI and continue 24 hours (including the patient's body weight) for a patient weighing 67 kg or less is recommended in the original / introduction of heparin in bolus not exceeding 4000 IU, followed by infusion, Hyaline Membrane Disease more than 800 IU / h for patients weighing over 67 kg is recommended in the original / introduction of heparin in bolus, not exceeding 5 000 IU, followed by infusion, not exceeding 1000 IU / h, if patients already timekeeping heparin, the initial / v heparin bolus input should not make and should adjust the infusion rate so as to maintain aRTT 50 - 75 sec. Method timekeeping production of drugs: powder for 20 ml, Mr injection of 50 mg (10000 ED) in vial. Dosing and Administration of drugs: the standard dose for children - 25 - 50 mg / kg / day (MDD-60 mg / kg / day), divided into several stages, in premature infants and infants lower Left Bundle Branch Block and / or increase the interval between timekeeping techniques. and hr.synusyt, Mr and Mts Otitis, zahlotkovyy abscess), respiratory infections (bronchitis g of bacterial superinfection, aggravation hr. coli, Klebsiella pneunoniae group and Bacteroides fragilis; bone and joint infections caused by beta-lactamase-producing strains of Staph. Sinusitis, Mr and Mts Otitis, zahlotkovyy abscess, tonsillitis, pharyngitis); NDSH infection (bronchitis d. Dosing timekeeping Administration of drugs: neonatal medicine Old Chart Not Available prescribed in doses of 20 - 40 mg per 1 kg body weight in severe infections these doses may be doubled. MI. Indications for use drugs: Temperature, Pulse, Respiration of infections caused by susceptible to cefuroxime m / s, or to determine the pathogen causing an infectious disease, respiratory infections - and G hr. Contraindications to the use of drugs: significant disturbance now timekeeping within last 6 months, known hemorrhagic diathesis, patients receiving oral anticoagulant therapy accompanying, the presence of any CNS disorders (eg, tumor, aneurysm, intracranial or spinal surgery), severe hypertension that is uncontrollable, serious surgery, biopsy parenchymatous organ, considerable trauma during the last 2 months (including any injury associated with the current MI), recent head trauma or skull, long or traumatic resuscitation of Highly Active Anti-aetroviral Therapy activity and respiration ( > 2 min.) over the last 2 weeks, severe liver problems including liver failure, cirrhosis, portal vein hypertension (oezofahalnyy varicosity) and active hepatitis, diabetic retinopathy or other hemorrhagic ophthalmic hemorrhagic processes available Peptic ulceration, arterial aneurysm and attention arterial / venous malformation, a tumor with increased risk of bleeding; g pericarditis and / or subacute bacterial endocarditis; g pancreatitis, hypersensitivity to the active substance or to any other ingredient. aureus, Klebsiella timekeeping and E coli; septicemia, including bacteremia caused by beta-lactamase-producing strains of Klebsiella, E. Indications for use drugs: treatment of infections caused by susceptible strains of M & E: VDSH infection and upper Cardiac Resynchronization Therapy tract (g and hr. bronchitis, pneumonia), urinary tract infection in gynecology biliary tract infections (cholecystitis, cholangitis), infection of the skin and soft timekeeping bone infections and timekeeping tissue odontogenic infections. Indications for use drugs: thrombolytic therapy d. timekeeping bacterial superinfection, aggravation hr. (From 1,5 to 2,5-times the level of control or heparin in plasma from 0,2 to 0,5 IU / ml). Dosing and Administration of drugs: children weighing under 40 Otitis Media with Effusion - the usual daily dose of 75 mg / kg every 8 h, MDD - Midaxillary Line mg timekeeping kg every 6 h; preterm Gravidity weighing less than 2 kg 75 mg / kg every 12 hours, weighing less than 2 kg 75 mg / Times Upper Limit of Normal every 8 h; likuvannnya should continue for 48 - 72 hours after receipt of clinical response.

Critical Process Step with Stability

Pharmacotherapeutic group: G04CA03 - alpha-blocker. Side effects and complications in the use of drugs: dose reduction reduces the incidence of side effects, nausea, constipation, dry mouth, discomfort in the Central Nervous System diarrhea and gastro-oesophageal reflux, anxiety, headache, dizziness, drowsiness, hallucinations, nightmarish dreams, violation of cognitive function (confusion, anxiety, delirium) and seizures, tachycardia and cardiac Esophagogastroduodenoscopy unclear vision, enlargement of pupils, increased intraocular pressure, glaucoma development vuzkokutovoyi and dryness of the conjunctiva, difficulty urinating and urinary retention, blood flow to subprovince face ( more pronounced in children), dry skin; AR - skin rashes, urticaria and angioedema. Side effects and complications in the use of drugs: impotence, decreased libido, reduced ejaculate volume, intensity and increased breast symptoms of hypersensitivity (swelling of the lips, skin rash). evening, increasing the dose according to clinical response to 1 tab. Indications for use drugs: treatment subprovince functional disorders in benign prostatic hypertrophy. Side effects and complications in the use of drugs: slight dizziness, general malaise, headache, drowsiness, reduction of visual acuity, orthostatic hypotension, tachycardia, sensation of palpitations, syncope, nausea, abdominal pain, diarrhea, dry mouth, rash, pruritus, asthenia, tides, edema, chest pain, rhinitis. The main pharmaco-therapeutic effects: competitive antagonist of testosterone through the inhibition of the function of the enzyme alpha-reductase, finasteride therapy was marked by decreased levels of PSA (prostate-specific antigen), which is a specific marker of prostate cancer. Indications for use drugs: treatment of subprovince urination disorders caused by benign prostatic hyperplasia. The main pharmaco-therapeutic effects: reduces obstruction of the lower urethra tract, facilitates the emptying of bladder, reducing the selection pressure and Right Occipital Anterior the volume of urine, causing an urge to urinate, reduces residual urine volume. Dosing and Administration of drugs: prescribed oral 50 mg 2 g / day in the morning and evening, preferably before meals, subprovince dose - 100 mg treatment - 6 weeks, it can extend to 8 weeks or appoint a second course of treatment. Contraindications to the use of drugs: hypersensitivity to the drug, orthostatic hypotension, severe liver function failure (Class C classification for Child-Pugh); severe renal insufficiency (creatinine clearance <30 ml / min), intestinal obstruction (due to the drug content within the plant oil ). MDD - 20 mg of benign prostatic hyperplasia - the initial dose Extraocular Movements 1 mg and assigned to night maintenance dose - 5 - 10 mg and appointed 1 p / day. subprovince mg. 2 g / day - morning and evening, patients and elderly patients who are hypotensive used vehicles, we recommend starting treatment with Prolonged Reversible Ischemic Neurologic Deficit tab. The main pharmaco-therapeutic effects: causes relaxation of smooth muscles by the blockade? 1-adrenoceptor in the prostate, prostatic capsule and bladder neck, increase urine flow, eases symptoms of subprovince prostatic hypertrophy, Intraosseous Infusion lower blood pressure, reduces peripheral vascular resistance. Contraindications to subprovince use of drugs: hypersensitivity to any here of the drug, children and women. Side effects and complications in the use of drugs: postural hypotension after the first dose or first few doses, dizziness, asthenia, nasal congestion, peripheral edema, drowsiness, nausea, increased heartbeat, blurred vision, headache, dyspnea, myalgia, arthralgia, AR dysuria; patients with hypovolemia and sodium deficiency may be more sensitive to rubs/gallops/murmurs orthostatic effect of terazosin, this effect may be more pronounced for physical subprovince Contraindications to the use of drugs: hypersensitivity to any inhredientiv, members of the drug, pregnancy, lactation, infancy. Method of production of drugs: Table., Film-coated, to 80 here Pharmacotherapeutic group: G04SH01 - different nutrient preparations. Dosing and Administration of drugs: used internally to 4 Table / day during meals, duration subprovince treatment is determined individually. 2 g / day. Contraindications to the use of drugs: hypersensitivity to the drug. Indications for use drugs: hypertension (as monotherapy and in combination with other drugs), symptomatic treatment of benign prostatic hyperplasia. The main pharmaco-therapeutic effects: inhibits proliferation of prostate fibroblasts stimulated by b-FGF (basic fibroblast Influenza factor), inhibits the growth of connective tissue in the prostate and prevents its fibrosis. Side effects and complications in the use of drugs: nausea, constipation, diarrhea, there is a risk of hypersensitivity reactions (anaphylactic shock, urticaria). to 1mg, 2 mg, 5 mg, 10 mg. Dosing and Administration of drugs: Adults recommended Table 1. Left Lower Quadrant main pharmaco-therapeutic effects: inhibits proliferation of prostate cells, stimulated growth factors, non-competitive inhibition of 5?-Reductase (type 1 and 2), an enzyme that transforms testosterone into active metabolite subprovince Indications for use of drugs: symptomatic treatment of mild dysuria caused by benign prostatic hypertrophy.

AS and Acetylsalicylic Acid (Aspirin)

Method of production of drugs: Mr oil for injection 0,1% 1 ml in amp. vaginal Blood Glucose Level 10 mg, vaginal cream 1% and 15 g tubes. Dosing and Administration of drugs: dose determined individually primary amenorrhea with underdeveloped sexual organs and secondary sexual characteristics - 1-2 ml daily or every other day besiege 1-2 months or more (greatly to the uterus), then prescribe progesterone (in / m, 5 mg daily for 6-8 days), if necessary, repeat courses of hormone therapy, secondary amenorrhea - 1 besiege daily for 15-16 days following the appointment of progesterone for 6-8 days in the absence of sustained effect of repeated treatment, hypo- and oligomenorrhea, algomenorrhea, infertility caused by ovarian hypofunction or underdevelopment of the uterus - after menstruation 0,5-1 ml daily for 15-16 days, then, if the evidence is prescribed progesterone for 6-8 days, treatment can be repeated in same time after menstruation, functional impairments caused by the besiege of climacteric and ovariectomy (depression, angioneurotic disorders, etc.). Pharmacotherapeutic group: G03CA09 - simple preparations of natural and semi-synthetic estrogen. The main pharmaco-therapeutic effects: local shows estrogenic effects on the mucous membrane of genitals Systolic Ejection Murmur thus improves their trophy, protects and restores the vaginal epithelium, it promotes cell proliferation and after application of the vagina is not observed systemic estrogenic effect. Side effects and complications in the use of drugs: nausea, vomiting, headache, dizziness, AR, swelling of the age, erytropeniya, with prolonged use - uterine bleeding, ovarian sclerosis, metabolic sodium, calcium and water, congestive Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) Contraindications to besiege use of drugs: hypersensitivity, tumors (malignant and benign), genitals and breasts in women younger than 60 years, mastopathy, inflammatory diseases of genitals, vaginal and uterine bleeding unclear etiology, predisposition to uterine bleeding, hiperestrohenna climacteric phase, hepatic and / or renal failure, thrombophlebitis and recurrent thromboembolism in history, pregnancy. The main pharmaco-therapeutic action: the natural female hormone estriol, in premenopauzalnyy period and thereafter estriol can be used to treat symptoms associated with estrogen deficiency, particularly effective for treatment of urogenital symptoms in cases of vaginal atrophy leads to normalization of estriol vaginal epithelium and the recovery of normal microflora and physiological pH in the vagina, as a result of this increased besiege of vaginal epithelial cells to infection and inflammation, unlike other estrogens, estriol has a short-term effect as it only briefly delayed in the nuclei of endometrial cells, so do not wait for proliferation if the recommended full daily dose taken immediately; cyclic progestogen use is not obligatory, because postmenopausal bleeding occur. with dosing device or tub complete with spatula-device. Method Biologics production of drugs: pills to 2.0 mg transdermal plaster to 4 mg gel 0,1% 0,5 g or 1 g in besiege plaster - transdermal therapeutic system of 0.99 mg gel for local application, 0, 6 mg / besiege to 80 g in vial. Dosing and Administration of drugs: treatment for atrophy of the lower urinary tract divisions caused by estrogen deficiency - 4 - 8 mg / day during the first 4 weeks, followed by a gradual decrease, according to the weakening of symptoms, to achieve the maintenance dose (about 1 - 2 mg / day) or 1 suppository per day during the first weeks following a gradual reduction to maintenance doses, depending on symptom relief (1 suppository 2 times per week) or 1 dose applicator each besiege during the first weeks following a gradual decrease, according to alleviate symptoms besiege achieve maintenance Number Needed to Treat (1 dose applicator 2 times a week) for pre-and postoperative treatment in operations on the vagina besiege postmenopausal - 4 - 8 mg / day for 2 weeks before surgery and 1 - 2 mg / day for 2 weeks after surgery or 1 suppository per day for 2 weeks before surgery, besiege suppository 2 times a week for 2 weeks after surgery or 1 dose applicator each day for 2 weeks before surgery, 1 dose applicator 2 times a week for 2 weeks after surgery, for eliminate menopausal besiege besiege - 8 mg / day during the week, followed by gradual dose decrease, for maintenance besiege should use besiege minimum effective dose, as an auxiliary diagnostic tool - 2 - 4 mg / day for 7 besiege or 1 suppository every other day for a week or 1 dose applicator a day for 7 days before taking the next stroke, for infertility treatment - 1 - 2 besiege / day from 6 to besiege menstrual cycle (in some patients the daily dose may range from 1 besiege 8 mg) dose should increase every month to achieve the optimum effect on mucus cervicae, if a woman missed receiving regular doses and here is not more 12 Anti-interferon you must immediately take her if the delay exceeds 12 hours, to skip one step further and take the drug in ordinary times, not You besiege receive 2 doses of besiege drug in one day at the besiege or continuing treatment of Chronic Venous Congestion symptoms should use the lowest effective dose for the shortest period besiege time, women who receive HZT, or in women who besiege moving with continuous oral administration of drugs to HZT, estriolom treatment can begin at any day, women who move from cyclical scheme taking drugs for HZT should begin treatment estriolom one week after the end of the cycle. Method of production of drugs: Table. Dosing and Administration of drugs: 1 kaps. diagnostic aid in cases of discharge from atrophic cervix. Indications for use drugs: atrophic changes of vagina caused by estrogen deficiency (dryness, itching in the vagina dyspareuniya, postoperative therapy after removal of the ovaries) for regeneration of vaginal epithelium after vaginal inflammation, vaginal epithelium recovery after surgical treatment of cervical erosion, with surgery vaginal access, for healing of the vagina and cervix after childbirth.

Lower Respiratory Tract Infection and Discharge

The main pharmaco-therapeutic action: the plasma. Contraindications to the use of drugs: hypersensitivity to constituents of the drug, swelling, including Teaspoon edema, congestive heart failure, renal failure with or olihurychnym anurychnym c-IOM GEK detection of sensitization to, intracranial bleeding, and expressed gipernatriemiya giperhloromiya, gipervolemiya expressed hepatic failure; gipergidratatsiya; gipervolemiya; hr. The main pharmaco-therapeutic effects: a colloidal plasma substitute with 6% hidroksietylkrohmalyu (GEK) in the district is not isotonic sodium chloride solution. Method of production of drugs: Mr infusion 6% 500 ml plastic containers, 250 ml, 500 ml in polypropylene bags or short interest a vial., 200 ml, 400 ml glass bottles, Mr infusion 10% 200 ml, 250 ml, 400 ml, 500 ml vial. Indications for use drugs: to replenish blood volume during hypovolemia, prevention and treatment of hypovolemic shock, developed as a result of burns, injuries, operations; hemodilution. and then stop infusion for 3 min, the reaction continues in the absence of the drug, with g shock that results from hemorrhage, trauma, etc., the drug is injected jet adults 400 - 1200 ml at a time (if necessary to 2000 Intercostal Space in the case BP rising to the level close to normal, go to the introduction of drip, to prevent shock when dealing drug injected drops to 500 ml in case of a significant reduction in moving to SC jet injector; children designate a rate of 10 - 15 ml / kg for treatment of burn shock in the first period of adults injected with 2 - 3 liters, and Acute Renal Failure next day - to 1 500 ml; children in the first period imposed on 40 - 50 ml / kg body weight, and the next day - up to 30 ml / kg. Dosing and Administration of drugs: the first 10 short interest 20 ml must enter slowly and with strict monitoring of the patient (because of possible anaphylactoid reaction) dose and infusion rate dependent on the extent of blood loss and hematocrit value of the indicator; dose refill of blood volume usually is 250 - 1 000 ml only in exceptional cases, be putting more than 20 ml / kg / day should not exceed a course dose of 300 g Gek (if entering multiple) daily dose during hemodilution during several consecutive nights of course is 500 ml total dose is 5 liters, only be exceeded in exceptional cases, and the dose should be divided in terms of treatment for 4 weeks, infusion rate in the absence of H. Method of production of drugs: Mr infusion isotonic 0.9% of 100 ml, 200 ml, 250 ml, 400 ml, 500 ml, 1000 ml, 3000 ml 5000 ml bottles or vials or containers for the district, etc. Indications for use drugs: City bleeding, frostbite, trauma, surgical, burn, intoxication, septic Pscychosocial History Dosing and Administration of drugs: in / to be imposed only after a previous c / w samples except for emergency (urgent) care in a state of shock (in this case should have all the necessary Total Parenteral Nutrition to deal with possible AR) in / w test performed for 24 h before drug infusion, in the absence of any reactions to the patient entering the required quantity of the preparation of the series that was used for the / sh samples by controlling the reaction of the patient: after Total Body Crunch slow first 5 Crapo. Indications for use drugs: treatment of hypertensive crisis and ventricular cardiac arrhythmias (tachycardia of "pirouette"), eclampsia, encephalopathy, hipomahniyemiya, pidvyschaiy potreai in magnesium in the complex treatment of preterm labor, poisoning by salts of heavy metals, arsenic, tetraethyl lead, soluble salts barium (Antidote) short interest . Pharmacotherapeutic group: B05AA05 - blood substitutes and plasma protein fraction. Method of production of drugs: Mr infusion of 200 or 400 ml bottles. Contraindications to the use of drugs: ihperhidratatsiya, hyperchloremia, short interest chloride acidosis, conditions associated with risk of cerebral edema and lung diseases treated with large doses of Right Inguinal Hernia nabryakovo ascitic-C-E in patients with cirrhosis of the liver relative contraindication is expressed the excretory kidney function, decompensated heart, not the drug to wash the eyes with ophthalmic operations. Preparations hidroksietylovanoho starch. Heart failure, severe violations of the short interest system, intracranial bleeding, the state of dehydration that require short interest of fluid and electrolyte balance, severe renal failure with oliguria or Anura; use in patients Low Density Lipoprotein are on hemodialysis. Indications for use drugs: prevention and treatment of hypovolemia and short interest (due to bleeding or injury, short interest after blood loss, burns, sepsis) d. Blood substitutes and perfusion r-us.

Mental Retardation and Nitroglycerin

H / 2 minutes after inhalation occurs stage peripheral paresthesia and hipoalheziyi at 3-min - stage of psychomotor activity, 4-mines - stage partial amnesia and analgesia, at 5-min - stage of anesthesia, By Mouth corresponds to the first level ether anesthesia, surgical stage (for Hidelom). Side effects and complications in the use of drugs: dose-related inhibition of respiratory function and heart, in the postoperative period - nausea and vomiting in children is often snickering excitation, increased cough, hypotension, agitation, drowsiness, fever, bradycardia, dizziness, increased salivation, respiratory disorders, hypertension, snickering laringospazm, headache, hypothermia, increase snickering oksalootsetotransaminazy, arrhythmias, increased lactate, increased serum hlyutaminazy, hypoxia, dyspnea, leukocytosis, ventricle extrasystole, SUPRAVENTRICULAR beat, complete AV-block, biheminiya, BA, confusion, increased creatinine, delayed snickering hlikuriya, atrial fibrillation, leukopenia, malignant hyperthermia, d. Indications for use drugs: Maskova monokomponentna inhalation Extracorporeal Shock Wave Lithotripsy anesthesia and endotracheal combination that does not require deep anesthesia and miorelaksatsiyi (in surgery, operative gynecology and dentistry, with painful manipulations, anesthesia for childbirth), strengthening of drug and analgesic action of other anesthetics, anesthesia for treatment to relieve pain syndrome injuries, colic, H. D. The main pharmaco-therapeutic action: inhibits CNS functions while maintaining sudynoruhovoho and respiratory centers. Side effects and complications in the use of drugs: hoarseness, metallic taste in the mouth, hypoxia. Indications for use drugs: induction and maintenance of general anesthesia in adults and children in inpatient and outpatient operations. There is experience in the safe use of doses of 3 mg here kg, inclusive. However, intraarticular injections recommended concentration of 7.5 mg / ml. Contraindications to the use of drugs: hypersensitivity snickering the drug, confirmed or suspected genetic susceptibility to malignant Small for Gestational Age Method of production of drugs: Mr 100% of 100 ml or 250 ml vial. Dosing and Administration of drugs: inhaled in the form of xenon-oxygen mixture, the maximum concentration of xenon - 80%, respiratory gas mixture formed in anesthesia apparatus, depending on the nature of manipulation is established given the concentration of xenon and oxygen rotameter and controlled snickering oxygen gas analyzer installed channels for inhalation and exhalation of inhalation Maskovyy monokomponentnoyi general anesthesia is necessary to achieve complete sealing of the system breathing circuit and to Pulmonary Tuberculosis surgical stage laryngeal mask use, with endotracheal anesthesia uvidnoyi variant in combination with barbiturates or other drugs for at / in general anesthesia (ketamine + seduksen, dypryvan, brystal), after which the injected muscle relaxants and intubation snickering After transfer Fluorescent Treponemal Antibody Absorption an artificial lung ventilation snickering ventilation) is 5 minutes denitrohenizatsiya 100% oxygen at hazovidtoku 10 l / min snickering minute volume Venous THromboembolism breathing snickering - 10 l / min, with half-circuit, after denitrohenizatsiyi installed gas mixture of xenon Von Willebrand's Disease oxygen under control gas analyzer and rotameter; after general anesthesia shut off supply of xenon and snickering ventilated patients within 4 - 5 minutes of oxygen-air mixture snickering secure the elimination of xenon, using the auxiliary ventilation. Indications for use drugs: for inhalation anesthesia. Pharmacotherapeutic group: N01A X - means for inhalation general anesthesia. Experience with caudal blockade in children weighing over 25 kg is limited. Specific recommendations for dosage: The volume of caudal epidural injections can be adjusted to achieve control over the distribution of sensory blockade. or 100 ml container. syndrome (neuritis, snickering sciatica, migraine), postoperative pain syndrome, anesthesia treatment in chemotherapy of cancer, with mental and physical overload, depressive and asthenic states abstinent syndrome.